Take Advantage of the Read-and-Publish Agreement for RUP Journals

Rockefeller University Press (RUP) has signed an unlimited Read-and-Publish agreement with Jisc. The agreement covers RUP's three hybrid journals: Journal of Cell Biology (JCB), Journal of Experimental Medicine (JEM),  and Journal of General Physiology (JGP).

How researchers immediately benefit from the agreement:

• Read: Unlimited access to all content published in JCB, JEM, and JGP immediately after publication.
• Publish: 100% coverage of the Immediate Open Access fees on any accepted manuscript when the primary corresponding author is based at a participating institution. There is no limit to the number of articles that may be published as a part of the deal.

Open Access research articles are published under a CC-BY license, directly deposited to PubMed Central (PMC) and subsequently to Europe PMC, and archived in LOCKSS/CLOCKSS.

The two-year agreement runs from January 2022 until December 2024.

Take advantage now: publication fees will be completely covered for articles by primary corresponding authors affiliated with your institution that were accepted during the term of the agreement.

Institutions that are participating in the Jisc RUP Read-and-Publish include:

Learn more about the "Rockefeller University Press Read-and-Publish Transitional Agreement 2023–2024" and take advantage of the pilot agreement through the Jisc licence subscriptions manager.